Qatar Pharmaceuticals Market Research Report: Forecast (2025-2030)

Market Insights & Analysis: Qatar Pharmaceuticals Market (2025-30):

The Qatar Pharmaceuticals Market size is valued at around USD 532 billion in 2025 and is projected to reach USD 698 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.58% during the forecast period, i.e., 2025-30. The Qatar Pharmaceutical Industry is gaining traction due to several growth factors, including the growing number of people affected by severe diseases & infectious diseases, the active government support through heavy investments, and the adoption of e-pharmacy due to the presence of fewer manufacturing units for pharmaceutical products. One of the most prominent growth factors is the rapidly growing aging population in the country, which is highly vulnerable to these diseases due to its weak immune system. Approximately, as of 2023, thousands of individuals were over 65 years old, which is further projected to increase up to 7,00,000 individuals by the end of 2049. Consequently, this surging elderly population is increasing the market demand.

Additionally, the national government is allocating significant funds for the expansion of pharmaceutical production units in the country to avoid dependence on imports. Also, the companies are heavily investing in the integration of smart technologies in the manufacturing units to enhance the pharmaceutical industry, thus contributing to the potential market growth & expansion.

Moreover, the usage of smartphones and high internet penetration in the country have led to the adoption of e-pharmacy, which is actively transforming the Qatar Pharmaceutical Market, as these are more convenient and offer faster deliveries over traditional pharmacies. However, the lack of production units results in high import reliance, thus hindering further market growth & expansion.

Qatar Pharmaceuticals Market Scope:

Qatar Pharmaceuticals Market Driver:

Increasing Cases of Chronic Disorders – The market growth is driven by the high incidence of chronic disorders in the country, including respiratory disorders, cardiovascular diseases, diabetes, etc., which require proper medications and treatments, thus ultimately increasing the demand for a well-established pharmaceutical industry in Qatar. For instance, as of 2024, over 390,000 individuals are suffering from diabetes in the country, while about 20% of the total population of Qatar is living with cardiovascular diseases.

Additionally, the high prevalence of cancer in the country is also contributing to the market growth. For instance, in 2023, nearly 1,989 new cancer cases were reported in Qatar. This kind of high disease burden has increased the growth of the pharmaceutical industry in the country. Consequently, the annual drug production has increased, and over 100 pharmaceutical product varieties are present to meet the growing national demands, thus augmenting the size & volume of the Pharmaceutical Industry of the country.

Qatar Pharmaceuticals Market Opportunity:

Increasing Government Support – The active support of Qatar’s government in expanding the manufacturing facilities for pharmaceutical products in the country, by heavy investments and incentives, is providing lucrative growth opportunities to the market players. For instance, Invest Qatar (2025) invested about USD1 billion to offer financial help for the technology-intensive industries, including the pharmaceutical industry.

Additionally, Qatar’s National Manufacturing Strategy (2024-2030) is focused on improving the manufacturing sectors, including the pharmaceutical industry, by integrating smart technologies in these facilities. For instance, Sidra Medicine launched a Good Manufacturing Practice (GMP) facility to make personalized and advanced drugs quickly and safely. In 2025, this facility received about USD100,000 to develop a smart platform for CAR-T cell therapy for the treatment of cancer. These efforts are contributing to the potential market growth & expansion.

Qatar Pharmaceuticals Market Challenge:

Lack of Manufacturing Units – Qatar has a shortage of pharmaceutical manufacturing plants, which forces the country to be highly dependent on imports for pharmaceutical products, including drugs and raw materials, which is a major challenge in this market. Qatar has only 10-12 pharmaceutical manufacturing plants, resulting in a high dependence on imports from other countries. For instance, about 97% of the total pharmaceutical products are imported into the country.

The country frequently experiences delays in the pharmaceutical products due to supply chain disruptions, political issues, natural disasters, etc., which ultimately leads to the shortage of important drugs in the country. Additionally, the import tax, shipping costs, and currency changes are further increasing the overall costs of these products, thus decreasing their accessibility and restraining further market growth & expansion.

Qatar Pharmaceuticals Market Trend:

Concept of E-Pharmacy Gaining Momentum – The market is gaining momentum due to the rising adoption of e-pharmacy in the Qatar Pharmaceutical Industry, supported by highly convenient and faster home deliveries. This trend is rapidly growing in the country because Qatar lacks sufficient production units for the manufacturing of pharmaceutical products. For instance, there are more than 10 e-pharmacy platforms in Qatar as of 2025, which shows the rapid expansion of these facilities in the country, thus uplifting the sales revenue in this industry.

Moreover, several companies, such as MedlQ, Qatar Pharma, Sunlife Online Pharmacy, etc., are heavily investing in the expansion of the e-pharmacy in the country to increase their market size & share. For instance, in 2025, MedlQ is a Pakistani company providing e-pharmacy, allocated USD6 million in funding, led by the joint venture of Qatar and Saudi Arabia, to increase its expansion in countries like Qatar, thus actively transforming the market growth trajectory.

Qatar Pharmaceuticals Market (2025-30): Segmentation Analysis

The Qatar Pharmaceutical Market study of MarkNtel Advisors evaluates & highlights the major trends and influencing factors in each segment. It includes predictions for the period 2025–2030 at the national level. Based on the analysis, the market has been further classified as:

Based on Product Type:

• Prescription Drugs
• Over-the-counter Drugs
• Biologics & Biosimilar

Among these, the prescription drugs are dominating the market, accounting for approximately 75% share of the market. These are dominating due to the high burden of chronic diseases in Qatar, which requires the recommendation of doctors for better prevention and cure. Additionally, customers have trust in prescription drugs because these are recommended by doctors, thus contributing to market growth. Also, these drugs have widespread adoption and usage for a variety of diseases like diabetes, respiratory diseases, tuberculosis, cardiovascular diseases, and many more, thus creating a high demand in the market.

Moreover, prescription drugs are highly affordable and easily available over other types of drugs. Consequently, millions of prescription drugs are produced in the country per year, showing their dominance in the Qatar Pharmaceutical Market. 

Based on Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Wholesale Stores
• Specialty Stores

Out of these, the hospital pharmacies hold the largest market share of about 28%. The factor contributing to the market’s growth is the large volume of patient visits to hospitals for regular check-ups, so they prefer to take medications from the corresponding hospital pharmacies. Additionally, the customers’ trust related to pharmacies in hospitals is contributing to the market’s growth. Therefore, there are about 200 hospitals in Qatar, and many of these have their pharmacies, showing their dominance in the market.

Also, hospital pharmacies are integrated with healthcare services such as diagnostics and treatment, making them convenient for patients to get prescribed medicines quickly, improving treatment adherence. This is due to some of the medications being prescription drugs only, that is only written in hospitals during checkups, so it makes it easier for the patients to purchase the drugs from the nearest distribution channel, that is, the hospital pharmacies, thus leading the market segment.

Qatar Pharmaceuticals Industry Recent Development:

• 2025: QLife Pharma introduced new health products focused on thyroid disease and vitamin D deficiencies. These products aim to help women stay healthier and improve overall wellness. This launch shows QLife Pharma’s strong commitment to women’s health and providing better care through advanced medical tests and treatments.

Gain a Competitive Edge with Our Qatar Pharmaceuticals Market Report

1. Qatar Pharmaceuticals Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
2. This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
3. Qatar Pharmaceuticals Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.